News About: Pharm. Industry
Drug makers unnerved by shortsightedness
Korea’s drug companies have stepped up efforts to expand the scope of its role by actively participating in the government-initiated job creation campaign and boosting their shrinking marketing activities.
Ironical...
Sanofi releases Cenovis brands
Sanofi-Aventis Korea is bringing Cenovis Pro, one of the most trusted names in Australia's health care industry, to the nation’s pharmacy market, thus expanding its business horizons beyond the traditional pharmaceuti...
Generic Viagra market overheated
Nearly 50 kinds of Viagra generics from 28 companies have flooded the market since the Intellectual Property Tribunal ruled last year that Pfizer’s patented rights to use sildenafil, an active ingredient essential to ...
Viread Science Korea release positive clinical results on Viread
Viread Science Korea Thursday announced new data from follow-up studies in China, Korea and Europe, which compared Viread (tenofovir disoproxil fumarate) to Hepsera (adefovir dipivoxil) over 48 weeks of treatment amon...
Bacchus-D, Vita 500 prevails in energy drink market
In the past few years, public demand has grown for energy drinks available outside pharmacies.
Thus far, the domestic energy drink market has been dominated by Dong-A Pharmaceutical’s Bacchus-D and Kwangdong Pharm...
Hanmi Pharm seeking regulatory approval for new combination formulation of irbesartan and atorvastat
Hanmi Pharmaceutical said Wednesday that it has filed a new drug application for its combination formulation containing irbesartan and atorvastatin to obtain the market authorization from to the Ministry of Food and D...
KFDA approves subcutaneous formulation of Orencia for rheumatoid arthritis
The Ministry of Food and Drug Safety (MFDS) has approved a subcutaneous formulation of Orencia (abatacept; BMS Korea) for the reduction of signs and symptoms in adults with moderate to severe rheumatoid arthritis.
...
Drugmakers increase cashable assets amid unpredictable market factors
Korea’s pharmaceutical firms are choosing to hold more of their earnings in cashable assets as they find it harder to invest amid growing market uncertainties and global economic slump.
Cashable assets include cash...
Lilly’s Cialis grabs bigger market share
Lilly Korea, a Korea unit of U.S.-based Eli Lilly & Co., is expanding its share of the domestic anti-impotence drug market.
The market share of Cialis 5mg has passed the 10 percent mark for the first time since its...
Daiichi-Sankyo Korea chief to head KPMA’s special committee
The special committee for Japanese drug firms in Korea, under the umbrella of the Korea Pharmaceutical Manufacturers Association (KPMA), said Tuesday that it appointed Kim Dae-joong, chief executive of Daiichi-Sankyo ...
